Meeting
2018 Palliative and Supportive Care in Oncology Symposium
Chemical coping and efficacy of buprenorphine for cancer pain.
Authors
Amy Allen Case
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Amy Allen Case, Eric Hansen, Chitra Nadagoundla, Chong Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Advance Care Planning; Caregiver Support; Coordination and Continuity of Care; End-of-Life Care; Models of Care; Survivorship; and Symptom Biology, Assessment and Management
Track
Advance Care Planning,End-of-Life Care,Survivorship,Coordination and Continuity of Care,Symptom Biology, Assessment, and Management,Models of Care,Caregiver Support
Sub Track
Symptom Biology, Assessment, and Management
Citation
J Clin Oncol 36, 2018 (suppl 34; abstr 200)
DOI
10.1200/JCO.2018.36.34_suppl.200
Abstract #
200
Poster Bd #
F2
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Quality Care Symposium
An evaluation of adult cancer-related neuropathic pain treatment at a large academic medical center.
First Author: Elizabeth Kyung Ko
Poster
2020 ASCO Virtual Scientific Program
Frequency and prediction of non-medical opioid use behaviors (NMOU) among advanced cancer patients referred to a supportive care center (SCC).
First Author: Sriram Yennu
Poster
2019 ASCO Annual Meeting
Patient controlled analgesia (PCA) versus non-PCA intravenous hydromorphone titration for severe cancer pain: A randomized, controlled, multicenter, phase III trial, HMORCT09-1.
First Author: Rongbo Lin
Poster
2018 Palliative and Supportive Care in Oncology Symposium
An association between tobacco smoking, daily opioid use, pain response and the risk for aberrant opioid use behaviors.
First Author: Sriram J. Yennu